Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $213.7700 (-0.1%) ($213.0350 - $213.7700) on Wed. Nov. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.77% (three month average) | RSI | 45 | Latest Price | $213.7700(-0.1%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IGOV(30%) IWF(17%) TLT(17%) LQD(15%) VCSH(15%) | Factors Impacting SGEN price | SGEN will decline at least -0.385% in a week (0% probabilities). IBUY(-35%) XME(-34%) REMX(-32%) XOP(-26%) ICLN(-25%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.385% (StdDev 0.77%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $214.9 | 5 Day Moving Average | $214.34(-0.27%) | 10 Day Moving Average | $214.3(-0.25%) | 20 Day Moving Average | $214.9(-0.53%) | To recent high | -1.6% | To recent low | 10.9% | Market Cap | $37.167b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |